Inflammatory Conditions research hub

A two-part trial in healthy volunteers to find out how long JNJ-77242113 stays in and acts on the body when administered as different tablet formulations and under different food and water conditions, and to assess the acceptability profile (taste, palatability, and smell) of JNJ-77242113 formulations.

This study is testing a new medicine, JNJ-77242113, that might help with swelling and irritation in the body. We want to see how long it stays in healthy people and how different ways of taking it (like with or without food) affect it, and if it tastes okay.

A study to evaluate the safety and tolerability of JNJ-70035108 and to evaluate how long JNJ-70035108 stays in and acts on the body (pharmacokinetics) when given as single and repeated doses to healthy participants

This study is looking at a new medicine called JNJ-70035108. It's for healthy volunteers and aims to see if the medicine is safe and how it works in the body. This is one of the first times it's being tested in people.

A Phase 1, Open-label, Randomized, Crossover Study to Assess the Effect of Different Types of Co-administered Oral Liquids on the Relative Oral Bioavailability of a JNJ 77242113 Tablet Formulation in Healthy Participants.

This study looks at how different drinks affect the body's absorption of a new tablet for inflammatory conditions. Healthy adults will try the tablet with various liquids to see if it works best with certain ones. It's an early-stage study to understand how the medication behaves.

A Single-dose, Open-label, Randomized, Crossover Study to Assess the Relative Oral Bioavailability of a JNJ-77242113 Phase 3 Immediate-release Tablet Formulation with Respect to the Phase 2 Immediate-release Tablet Formulation and to Assess the Food Effect of a JNJ-77242113 Phase 3 Immediate-release Tablet Formulation in Healthy Participants